Details for New Drug Application (NDA): 215460
✉ Email this page to a colleague
The generic ingredient in PEMETREXED DISODIUM is pemetrexed disodium. There are twenty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the pemetrexed disodium profile page.
Summary for 215460
Tradename: | PEMETREXED DISODIUM |
Applicant: | Hetero Labs Ltd Vi |
Ingredient: | pemetrexed disodium |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 215460
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 100MG BASE/VIAL | ||||
Approval Date: | Jun 14, 2024 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Jun 14, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription